Ketamine activates adult-born immature granule neurons to rapidly alleviate depression-like behaviors in mice

• Published in: Nature communications Vol. 13; no. 1; p. 2650
• Main Authors: Rawat, Radhika, Tunc-Ozcan, Elif, McGuire, Tammy L, Peng, Chian-Yu, Kessler, John A
• Format: Journal Article
• Language: English
• Published: England Nature Publishing Group 12.05.2022; Nature Publishing Group UK; Nature Portfolio
• Subjects: Animals; Antidepressants; Antidepressive Agents - pharmacology; Antidepressive Agents - therapeutic use; Dentate gyrus; Depression - drug therapy; Granular materials; Granule cells; Hippocampus; Ketamine; Ketamine - pharmacology; Ketamine - therapeutic use; Mice; Neurons; Side effects
• ISSN: 2041-1723; 2041-1723
• DOI: 10.1038/s41467-022-30386-5

Ketamine treatment decreases depressive symptoms within hours, but the mechanisms mediating these rapid antidepressant effects are unclear. Here, we demonstrate that activity of adult-born immature granule neurons (ABINs) in the mouse hippocampal dentate gyrus is both necessary and sufficient for the rapid antidepressant effects of ketamine. Ketamine treatment activates ABINs in parallel with its behavioral effects in both stressed and unstressed mice. Chemogenetic inhibition of ABIN activity blocks the antidepressant effects of ketamine, indicating that this activity is necessary for the behavioral effects. Conversely, chemogenetic activation of ABINs without any change in neuron numbers mimics both the cellular and the behavioral effects of ketamine, indicating that increased activity of ABINs is sufficient for rapid antidepressant effects. These findings thus identify a specific cell population that mediates the antidepressant actions of ketamine, indicating that ABINs can potentially be targeted to limit ketamine's side effects while preserving its therapeutic efficacy.